Katia Schlienger - Mar 9, 2023 Form 3 Insider Report for HOOKIPA Pharma Inc. (HOOK)

Role
Chief Medical Officer
Signature
/s/ Reinhard Kandera, Attorney-in-Fact
Stock symbol
HOOK
Transactions as of
Mar 9, 2023
Transactions value $
$0
Form type
3
Date filed
4/18/2023, 07:43 PM
Next filing
Apr 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HOOK Common Stock 1.3K Mar 9, 2023 By son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HOOK Stock Option (Right to Buy) Mar 9, 2023 Common Stock 28K $12.00 Direct F1
holding HOOK Stock Option (Right to Buy) Mar 9, 2023 Common Stock 17.8K $1.66 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest on February 15, 2022, with the remainder vesting in 12 equal quarterly installments thereafter.
F2 25% of this option shall vest on February 15, 2023, with the remainder vesting in 12 equal quarterly installments thereafter.

Remarks:

Exhibit 24.1: Power of Attorney